![Francine Del Ricci](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francine Del Ricci
Forschungsdirektor - Fxd Inc bei Teva Pharmaceuticals Ltd.
Profil
Francine Del Ricci is currently a Director at Cell Cure Neurosciences Ltd.
and a VP-Corporate Alliance Management at Teva Pharmaceuticals Ltd.
She was formerly a Director at Immuneering Corp.
Aktive Positionen von Francine Del Ricci
Unternehmen | Position | Beginn |
---|---|---|
Cell Cure Neurosciences Ltd.
![]() Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | - |
Teva Pharmaceuticals Ltd.
![]() Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Forschungsdirektor - Fxd Inc | - |
Ehemalige bekannte Positionen von Francine Del Ricci
Unternehmen | Position | Ende |
---|---|---|
IMMUNEERING CORPORATION | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IMMUNEERING CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
Cell Cure Neurosciences Ltd.
![]() Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
Teva Pharmaceuticals Ltd.
![]() Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Health Technology |